Merck Will Share Formula for its Covid Pill With Poor Countries

The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.

Source: NYT Health - October 27, 2021 Category: Consumer Health News Authors: Stephanie Nolen Tags: Molnupiravir (Drug) Medicine and Health Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Inventions and Patents Third World and Developing Countries Medicines Patent Pool Foundation Merck & Company Inc Ridgeback Biotherapeutics Emory Source Type: news